Publications by authors named "Larry Hayward"

Claim this Profile
G
Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcoma.
Piotr J Manasterski, Molly R Danks, John P Thomson, Morwenna Muir, Martin Lee, Larry Hayward

Mol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer.
Rita A Mukhtar, Soumya Gottipati, Christina Yau, Sara López-Tarruella, Helena Earl, Larry Hayward

NPJ Breast Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superficial soft tissue sarcomas: 10‑year survival outcomes.
Maria Tolia, Areti Gkantaifi, Larry Hayward, Girish Gupta, Anastasios Kyriazoglou

Oncol Lett· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gorham-Stout case report: a multi-omic analysis reveals recurrent fusions as new potential drivers of the disease.
Marcos Yébenes Mayordomo, Sofian Al Shboul, Maria Gómez-Herranz, Asim Azfer, Alison Meynert, Larry Hayward

BMC Med Genomics· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omic machine learning predictor of breast cancer therapy response.
Stephen-John Sammut, Mireia Crispin-Ortuzar, Suet-Feung Chin, Elena Provenzano, Helen A Bardwell, Larry Hayward

Nature· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Christina Yau, Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Larry Hayward

Lancet Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for improving access to clinical trials by teenagers and young adults with cancer: A qualitative study of health professionals' views.
Ruth I Hart, Dorothy Boyle, David A Cameron, Fiona J Cowie, Larry Hayward

Eur J Cancer Care (Engl)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Energetics Before, During, and After Anthracycline-Based Chemotherapy in Breast Cancer Patients Using P Magnetic Resonance Spectroscopy: A Pilot Study.
Gillian Macnaught, Olga Oikonomidou, Christopher T Rodgers, William Clarke, Annette Cooper, Larry Hayward

Front Cardiovasc Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of mouse models of angiosarcoma driven by p53.
Donald M Salter, Meredyth Griffin, Morwenna Muir, Katy Teo, Jayne Culley, Larry Hayward

Dis Model Mech· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
Carlo Palmieri, Rob C Stein, Xinxue Liu, Emma Hudson, Hanna Nicholas, Larry Hayward

Breast Cancer Res Treat· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
Carlo Palmieri, Rob C Stein, Xinxue Liu, Emma Hudson, Hanna Nicholas, Larry Hayward

Breast Cancer Res Treat· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.
Helena M Earl, Louise Hiller, Janet A Dunn, Clare Blenkinsop, Louise Grybowicz, Larry Hayward

Lancet Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study).
Pierre Fumoleau, Kevin M Koch, Etienne Brain, François Lokiec, Keyvan Rezai, Larry Hayward

Breast· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience.
Anna Maria Frezza, Charlotte Benson, Ian R Judson, Saskia Litiere, Sandrine Marreaud, Larry Hayward

Clin Sarcoma Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring mechanisms of acquired resistance to HER2 (human epidermal growth factor receptor 2)-targeted therapies in breast cancer.
Helen Creedon, Adam Byron, Joanna Main, Larry Hayward, Teresa Klinowska

Biochem Soc Trans· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial.
Stephen Rd Johnston, Lucy S Kilburn, Paul Ellis, David Dodwell, David Cameron, Larry Hayward

Lancet Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression.
Tom Latham, Logan Mackay, Duncan Sproul, Muhammed Karim, Jayne Culley, Larry Hayward

Nucleic Acids Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
Terry A Gray, Nicola J MacLaine, Caroline O Michie, Pavla Bouchalova, Euan Murray, Larry Hayward

J Immunol Methods· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance.
Shawna Mae Hengel, Euan Murray, Simon Langdon, Larry Hayward, Jean O'Donoghue

J Proteome Res· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitive, specific, and quantitative FTICR mass spectrometry of combinatorial post-translational modifications in intact histone H4.
C Logan Mackay, Bernard Ramsahoye, Karl Burgess, Ken Cook, Stefan Weidt, Larry Hayward

Anal Chem· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1.
Ling-Hua Meng, Hongliang Zhang, Larry Hayward, Haruyuki Takemura, Rong-Guang Shao

Cancer Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis